title: Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord.
abstract: We have previously demonstrated that multiple sclerosis (MS) patients have abnormal cerebrospinal fluid (CSF) levels of the key myelin-related molecules cobalamin (Cbl), epidermal growth factor (EGF), and normal cellular prions (PrP(C)s), thus confirming that some CSF abnormalities may be co-responsible for remyelination failure. We determined the levels of these three molecules in post-mortem spinal cord (SC) samples taken from MS patients and control patients. The control SC samples, almost all of which came from non-neurological patients, did not show any microscopic lesions of any type. All of the samples were supplied by the U.K. MS Tissue Bank. The Cbl, EGF, and PrP(C) levels were determined using enzyme-linked immunosorbent assays. The SC total homocysteine level was determined using a competitive immunoenzymatic assay. CSF samples, taken from a further group of MS patients, were used for the assay of holo-transcobalamin (holo-TC) levels. The Cbl, EGF, and PrP(C) levels were significantly decreased in MS SCs in comparison with controls and, paradoxically, the decreased Cbl levels were associated with decreased SC levels of homocysteine, a biochemical marker of Cbl deficiency. The trends of EGF and PrP(C) levels paralleled those previously found in CSF, whereas that of Cbl was the opposite. There was no significant difference in CSF holo-TC levels between the MS patients and the controls. Given that we have previously demonstrated that Cbl positively regulates central nervous system EGF levels, it is conceivable that the low EGF levels in the MS SC may be causally related to a local decrease in Cbl levels. Only PrP(C) levels were invariably decreased in both the SC and CSF regardless of the clinical course of the disease. These findings suggest that the simultaneous lack of Cbl, EGF, and PrP(C)s may greatly hamper the remyelination process in MS patients, because they are key molecules of the machinery for remyelination.
authors.affiliation: Department of Biomedical Sciences, Laboratory of Neuropathology, University of Milan, 20133 Milan, Italy. Electronic address: giuseppe.scalabrino@unimi.it.
authors.forename: G
authors.initials: G
authors.lastname: Scalabrino
authors.affiliation: Department of Biomedical Sciences, Laboratory of Neuropathology, University of Milan, 20133 Milan, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Veber
authors.affiliation: Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.
authors.forename: R
authors.initials: R
authors.lastname: De Giuseppe
authors.affiliation: Division of Brain Sciences, Imperial College, London W12 0NN, UK.
authors.forename: F
authors.initials: F
authors.lastname: Roncaroli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004815:Epidermal Growth Factor / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000473:pathology*; D011328:Prions / Q000378:metabolism*; D012720:Severity of Illness Index; D013116:Spinal Cord / Q000378:metabolism*; D014805:Vitamin B 12 / Q000378:metabolism*; D066127:White Matter / Q000473:pathology; D055815:Young Adult
chemical_list: D011328:Prions; D004815:Epidermal Growth Factor; D014805:Vitamin B 12
keywords: cobalamin; epidermal growth factor; holo-transcobalamin; multiple sclerosis; normal prions; spinal cord